PRTC
Price
$17.00
Change
+$0.22 (+1.31%)
Updated
Mar 11, 10:30 AM (EDT)
Capitalization
422.34M
44 days until earnings call
RNXT
Price
$0.93
Change
+$0.02 (+2.20%)
Updated
Mar 11, 04:59 PM (EDT)
Capitalization
32.36M
69 days until earnings call
Ad is loading...

PRTC vs RNXT

Header iconPRTC vs RNXT Comparison
Open Charts PRTC vs RNXTBanner chart's image
PureTech Health
Price$17.00
Change+$0.22 (+1.31%)
VolumeN/A
Capitalization422.34M
RenovoRx
Price$0.93
Change+$0.02 (+2.20%)
Volume$2.17K
Capitalization32.36M
PRTC vs RNXT Comparison Chart
Loading...
RNXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PRTC vs. RNXT commentary
Mar 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRTC is a Hold and RNXT is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 12, 2025
Stock price -- (PRTC: $16.78 vs. RNXT: $0.91)
Brand notoriety: PRTC and RNXT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PRTC: 56% vs. RNXT: 25%
Market capitalization -- PRTC: $422.34M vs. RNXT: $32.36M
PRTC [@Biotechnology] is valued at $422.34M. RNXT’s [@Biotechnology] market capitalization is $32.36M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.07B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRTC’s FA Score shows that 1 FA rating(s) are green whileRNXT’s FA Score has 0 green FA rating(s).

  • PRTC’s FA Score: 1 green, 4 red.
  • RNXT’s FA Score: 0 green, 5 red.
According to our system of comparison, PRTC is a better buy in the long-term than RNXT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RNXT’s TA Score shows that 4 TA indicator(s) are bullish.

  • RNXT’s TA Score: 4 bullish, 6 bearish.

Price Growth

PRTC (@Biotechnology) experienced а -8.28% price change this week, while RNXT (@Biotechnology) price change was -4.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.61%. For the same industry, the average monthly price growth was -8.15%, and the average quarterly price growth was -7.40%.

Reported Earning Dates

PRTC is expected to report earnings on Apr 24, 2025.

RNXT is expected to report earnings on May 19, 2025.

Industries' Descriptions

@Biotechnology (+0.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRTC($422M) has a higher market cap than RNXT($32.4M). PRTC YTD gains are higher at: -9.079 vs. RNXT (-29.457).
PRTCRNXTPRTC / RNXT
Capitalization422M32.4M1,302%
EBITDAN/A-10.12M-
Gain YTD-9.079-29.45731%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A9.56M-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
RNXT
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 22 days ago
88%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
RNXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X78532.000000-2069.039000
-2.57%
Bitcoin cryptocurrency
SPY560.58-15.34
-2.66%
SPDR® S&P 500® ETF Trust
AAPL227.48-11.59
-4.85%
Apple
GME22.42-1.58
-6.58%
GameStop Corp
TSLA222.15-40.52
-15.43%
Tesla

PRTC and

Correlation & Price change

A.I.dvisor tells us that PRTC and KZIA have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PRTC and KZIA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRTC
1D Price
Change %
PRTC100%
-6.50%
KZIA - PRTC
26%
Poorly correlated
-19.52%
NMRA - PRTC
24%
Poorly correlated
-10.07%
ELEV - PRTC
23%
Poorly correlated
-7.89%
CRGX - PRTC
23%
Poorly correlated
+1.26%
ALLK - PRTC
23%
Poorly correlated
-3.85%
More

RNXT and

Correlation & Price change

A.I.dvisor tells us that RNXT and SPRB have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RNXT and SPRB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNXT
1D Price
Change %
RNXT100%
-4.91%
SPRB - RNXT
29%
Poorly correlated
-1.19%
IMRX - RNXT
27%
Poorly correlated
-3.95%
VANI - RNXT
25%
Poorly correlated
-3.70%
CVKD - RNXT
24%
Poorly correlated
-8.49%
VTVT - RNXT
23%
Poorly correlated
-2.54%
More